Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alison Button‐Sloan"'
Autor:
John Zalcberg, Sue Evans, H Peter Soyer, Mark Shackleton, Graham Mann, Victoria Mar, Dale Jobson, Benjamin Roffey, Renee Best, Alison Button-Sloan, Danica Cossio, Catherine Shang, Julie Moore, Christopher Arnold, Rachel L Morton
Publikováno v:
BMJ Open, Vol 12, Iss 9 (2022)
Introduction Australia has the highest incidence of melanoma in the world with variable care provided by a diverse range of clinicians. Clinical quality registries aim to identify these variations in care and provide anonymised, benchmarked feedback
Externí odkaz:
https://doaj.org/article/9d5e8f8abf624747895b784bef5e312b
Autor:
Dale Jobson, Benjamin Roffey, Christopher Arnold, Anthony Azzi, Alison Button‐Sloan, Tamara Dawson, Pablo Fernandez‐Penas, Paul Fishburn, David E. Gyorki, Emma L. Hiscutt, Valerie Jakrot, Alister Lilleyman, Alistair Lochhead, Georgina V. Long, Sonia Mailer, Graham Mann, Christopher J. McCormack, Jim Muir, George F. Pratt, Richard A. Scolyer, Mark Shackelton, Stephen Shumack, H. Peter Soyer, Chin‐Guan Tan, Angela Webb, John Zalcberg, Rachael Morton, Victoria Mar
Publikováno v:
The Australasian journal of dermatologyREFERENCES. 63(3)
Clinical quality registries aim to identify significant variations in care and provide anonymised feedback to institutions to improve patient outcomes. Thirty-six Australian organisations with an interest in melanoma, raised funds through three conse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c152bab80c1c2394e1c2b82ba5bd3c4c
https://pubmed.ncbi.nlm.nih.gov/35486539
https://pubmed.ncbi.nlm.nih.gov/35486539
Autor:
Dale Jobson, Benjamin Roffey, Renee Best, Alison Button-Sloan, Danica Cossio, Sue Evans, Catherine Shang, Julie Moore, Christopher Arnold, Graham Mann, Mark Shackleton, H Peter Soyer, Rachel L Morton, John Zalcberg, Victoria Mar
Publikováno v:
BMJ Open. 12:e062139
IntroductionAustralia has the highest incidence of melanoma in the world with variable care provided by a diverse range of clinicians. Clinical quality registries aim to identify these variations in care and provide anonymised, benchmarked feedback t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed0a28e560d568eaff60ffc38d9bcf61
https://doi.org/10.1136/bmjopen-2022-062139
https://doi.org/10.1136/bmjopen-2022-062139
Autor:
Fiona A Lynch, Justine Diggens, Mark Shackleton, Haryana M. Dhillon, Hayley Burridge, Maria Ftanou, Lynda J Katona, Jane A. Elliott, Julia Lai-Kwon, Jo Phipps-Nelson, Allan Ben Smith, Victoria Dax, Michael Jefford, Joanne Shaw, Holly Kent, Donna Milne, Alison Button-Sloan, Steve Ellen, Lahiru Russell
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 2969, p 2969 (2020)
Journal of Clinical Medicine
Volume 9
Issue 9
Journal of Clinical Medicine
Volume 9
Issue 9
Immunotherapies and targeted therapies have revolutionised treatment of metastatic melanoma and improved survival rates. However, survivors treated with novel therapies are vulnerable to high levels of fear of cancer recurrence or progression (FCR).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::339eb8d77a0f8d869e86280a758e6072
https://www.mdpi.com/2077-0383/9/9/2969
https://www.mdpi.com/2077-0383/9/9/2969